Abnormalities of T lymphocyte subsets in systemic sclerosis and analyses of the inducing cytokines
系统性硬化症T淋巴细胞亚群异常及诱导细胞因子分析
基本信息
- 批准号:09670891
- 负责人:
- 金额:$ 0.77万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C).
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We examined the frequencies of interleukin (IL)-4 or IL-2 producing CD4^+ or CD8^+T cells in peripheral blood mononuclear cells (PBMC_5) from patients with systemic sclerosis (SSc). The frequency of CD4^+T cells was negatively correlated with duration of SSc, whereas the frequency of CD8^+T cells was not correlated with duration. The frequencies of IL-4 producing (IL-4^+) cells in CD4^+T cells and in CD8^+T cells from the patients with SSc were both significantly higher than those from the healthy controls. In contrast, the frequencies of IL-2 producing (IL-2^+) cells in CD4^+T cells and in CD8^+T cells from patients with SSc were both significantly lower than that from the healthy controls. Further, the ratios of IL-4^+/IL-4^+ + IL-2^+ in CD4^+T cells and in CD8^+T cells were both negatively correlated with the disease duration of SSc. These results suggest that type 2 cytokine-producing T cells, not only CD4^+T cells but also CD8^+T cells, have important roles in the pathogenesis of … More SSc, especially in the early phase of SSc. We then examined the effect of IL-12 encoding plasmid (pCAGGSIL-12) on the disease progression of Tsk/+ mice. pCAGGSIL-12 plasmid or pCAGGS parental vector was injected intramuscularly 7 times with 3 weeks intervals into Tsk/+ mice. One week after the last injection, pCAGGSIL-12 administered Tsk/+ mice exhibited a marked decrease in the skin thickness compared with the mice treated with pCAGGS vector. The serum levels of antinuclear antibodies were diminished in pCAGGSIL-12 treated mice. IL-4 production by spleen cells from pCAGGSIL-12 plasmid treated mice was significantly lower than that from vector treated mice. These results indicate that pCAGGSIL-12 administration into Tsk/+ mice had beneficial effects in preventing the collagen accumulation in the skin and suppressing the autoimmunity via improvement of Th1/Th2 balance. The present study suggests that the IL-12 encoding plasmid administration might have a therapeutic effect on systemic sclerosis. Less
我们检测了系统性硬化症(SSc)患者外周血单个核细胞(PBMC_5)中产生白细胞介素(IL)-4或IL-2的CD 4 ^+或CD 8 ^+T细胞的频率。CD 4 ^+T细胞的频率与SSc的持续时间呈负相关,而CD 8 ^+T细胞的频率与持续时间无关。SSc患者的CD 4 ^+T细胞和CD 8 ^+T细胞中产生IL-4(IL-4^+)细胞的频率均显著高于健康对照组。相比之下,SSc患者的CD 4 ^+T细胞和CD 8 ^+T细胞中产生IL-2(IL-2^+)细胞的频率均显著低于健康对照组。此外,CD 4 ^+T细胞和CD 8 ^+T细胞中IL-4 ^+/IL-4^+ + IL-2^+的比值均与SSc的病程呈负相关。这些结果表明,产生2型亮氨酸的T细胞,不仅是CD 4 ^+T细胞,而且是CD 8 ^+T细胞,在白血病的发病机制中具有重要作用。 ...更多信息 尤其是在SSc的早期。然后,我们检查了IL-12编码质粒(pCAGGSIL-12)对Tsk/+小鼠疾病进展的影响。将pCAGGSIL-12质粒或pCAGGS亲本载体以3周间隔肌肉注射到Tsk/+小鼠中7次。最后一次注射后一周,与用pCAGGS载体处理的小鼠相比,施用pCAGGSIL-12的Tsk/+小鼠表现出皮肤厚度的显著降低。在pCAGGSIL-12处理的小鼠中,抗核抗体的血清水平降低。来自pCAGGSIL-12质粒处理的小鼠的脾细胞的IL-4产生显著低于来自载体处理的小鼠。这些结果表明,将pCAGGSIL-12给予Tsk/+小鼠,通过改善Th 1/Th 2平衡,在防止皮肤中胶原积聚和抑制自身免疫方面具有有益效果。目前的研究表明,IL-12编码质粒的管理可能有系统性硬化症的治疗效果。少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
佐々木哲雄: "全身性強皮症(5)循環障害とその治療" Monthlg Book Derma.強皮症-その基礎と臨床-. No.12. 51-56 (1998)
Tetsuo Sasaki:“系统性硬皮病(5)循环障碍及其治疗”月刊硬皮病 - 其基础和临床实践 - 第 12 期。 51-56(1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Junko Tsuji-Yamada: "Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis"J Rheumatol. 28. 1252-1258 (2001)
Junko Tsuji-Yamada:“系统性硬化症患者外周血中产生白细胞介素 4 的 CD4 和 CD8 细胞的频率增加”J Rheumatol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
佐々木 哲雄: "Raynaud現象に対する治療「同上」" 診断と治癒社(宮地良樹,竹原和彦 編集), 238-241/251 (1997)
Tetsuo Sasaki:“雷诺现象‘同上’的治疗”Heureisha诊断(宫地芳树和竹原和彦编辑),238-241/251(1997)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
松倉 節子: "全身性強皮症とシェーグレン症候群の合併例に生じた悪性血管内皮細胞腫" 西日本皮膚科. 60(3). 335-339 (1998)
Settsuko Matsukura:“系统性硬化症和干燥综合征合并发生的恶性血管内皮瘤”Nishinippon Dermatology 60(3) (1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
三谷 直子: "急性腎不全およびびまん性肺出血をきたした抗好中球細胞質抗体陽性の全身性強皮症" 日本皮膚科学会雑誌. 108(5)(印刷中). (1998)
Naoko Mitani:“抗中性粒细胞胞浆抗体呈阳性的系统性硬皮病导致急性肾衰竭和弥漫性肺出血”,日本皮肤病学会杂志 108(5)(出版中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SASAKI Tetsuo其他文献
SASAKI Tetsuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SASAKI Tetsuo', 18)}}的其他基金
In-situ monitoring of crystal growth and deliquescence by laser spectroscopy
通过激光光谱法原位监测晶体生长和潮解
- 批准号:
24550214 - 财政年份:2012
- 资助金额:
$ 0.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on spectroscopic ellipsometry using GaP terahertz signal generator and its application for accurate measurement of film thickness
GaP太赫兹信号发生器光谱椭偏仪研究及其在薄膜厚度精确测量中的应用
- 批准号:
20560026 - 财政年份:2008
- 资助金额:
$ 0.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
The role of T lymphocyte subsets in the evolution and functional outcome of ischaemic stroke
T淋巴细胞亚群在缺血性中风的演变和功能结果中的作用
- 批准号:
nhmrc : 607210 - 财政年份:2010
- 资助金额:
$ 0.77万 - 项目类别:
NHMRC Postgraduate Scholarships
Differential localization of CD4ィイD1+ィエD1 T lymphocyte subsets.
CD4D1+D1 T 淋巴细胞亚群的差异定位。
- 批准号:
10670121 - 财政年份:1998
- 资助金额:
$ 0.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MURINE T LYMPHOCYTE SUBSETS AND ALLOGRAFT REJECTION
鼠 T 淋巴细胞亚群和同种异体移植排斥
- 批准号:
6099466 - 财政年份:1998
- 资助金额:
$ 0.77万 - 项目类别:
T LYMPHOCYTE SUBSETS AND HOST DEFENSE AGAINST P CARINII
T 淋巴细胞亚群和宿主针对 P CARINII 的防御
- 批准号:
6389817 - 财政年份:1997
- 资助金额:
$ 0.77万 - 项目类别:
T LYMPHOCYTE SUBSETS AND HOST DEFENSE AGAINST P CARINII
T 淋巴细胞亚群和宿主针对 P CARINII 的防御
- 批准号:
6184200 - 财政年份:1997
- 资助金额:
$ 0.77万 - 项目类别:
T LYMPHOCYTE SUBSETS AND HOST DEFENSE AGAINST P CARINII
T 淋巴细胞亚群和宿主针对 P CARINII 的防御
- 批准号:
2536826 - 财政年份:1997
- 资助金额:
$ 0.77万 - 项目类别:
T LYMPHOCYTE SUBSETS AND HOST DEFENSE AGAINST P CARINII
T 淋巴细胞亚群和宿主针对 P CARINII 的防御
- 批准号:
6056491 - 财政年份:1997
- 资助金额:
$ 0.77万 - 项目类别:
T LYMPHOCYTE SUBSETS AND HOST DEFENSE AGAINST P CARINII
T 淋巴细胞亚群和宿主针对 P CARINII 的防御
- 批准号:
2771640 - 财政年份:1997
- 资助金额:
$ 0.77万 - 项目类别:
T LYMPHOCYTE SUBSETS AND HOST DEFENSE AGAINST P CARINII
T 淋巴细胞亚群和宿主针对 P CARINII 的防御
- 批准号:
2766971 - 财政年份:1997
- 资助金额:
$ 0.77万 - 项目类别:
MURINE T LYMPHOCYTE SUBSETS AND ALLOGRAFT REJECTION
鼠 T 淋巴细胞亚群和同种异体移植排斥
- 批准号:
6234966 - 财政年份:1997
- 资助金额:
$ 0.77万 - 项目类别: